Jefferies Group LLC Revance Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 16, 2022
SELL
$12.36 - $20.31 $185,400 - $304,650
-15,000 Closed
0 $0
Q4 2021

Sep 21, 2023
BUY
$12.46 - $27.87 $186,900 - $418,050
15,000 New
15,000 $244,000
Q4 2021

Feb 14, 2022
BUY
$12.46 - $27.87 $186,900 - $418,050
15,000 New
15,000 $245,000

Others Institutions Holding RVNC

# of Institutions
232
Shares Held
82.1M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email